A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
University of Nebraska
Takeda
Perspective Therapeutics
Novartis
VM Oncology, LLC
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Merck Sharp & Dohme LLC
Travera Inc
Incyte Corporation
Incyte Corporation
Azienda Ospedaliera di Padova
A2 Biotherapeutics Inc.
Incyte Corporation
Instituto do Cancer do Estado de São Paulo
Turnstone Biologics, Corp.